Top 12 stocks in focus today: Sun Pharma, Lupin, Infratel
Vodafone Group Plc has valued its 42% stake in Indus Towers at $ 5 billion (around Rs 32,720 crore), as per media reports. Bharti Infratel, Vodafone India and Aditya Birla Telecom hold 42%, 42% and 16% shareholding, respectively, in Indus.
Lupin’s USFDA warning letter lists repeat observations for Indore and Goa plants.
Banks and financial institutions have approached NBCC (India) to develop some of the land assets that have been pledged with them by the promoters of defaulting firms, as per media reports.
Sun Pharma reported a 59% decline in fiscal-second quarter profit because of weak US sales. It’s consolidated revenue for the quarter came in at Rs 6,650 crore, registering 19.5% yoy decline.
Coal India is talking to the railways to increase rake loading from an average of 216 so far since April to 250 by the end of the fiscal year, as it seeks to meet increased demand, as per media reports.
Fortis Healthcare looks to buy RHT Heath Trust for a combined enterprise value of approximately Rs 4,650 crore.
HDIL to divest 60% in Ravijyot Finance and Leasing.
HCL Technologies signed a 5-year IT infrastructure services contract with Jardine Lloyd Thompson Group.
Ujjivan Financial Services clarified that reports of acquisition by another bank are incorrect.